Promiscuous Shiga toxin 2e and its intimate relationship to Forssman.
暂无分享,去创建一个
A. Friedrich | H. Karch | M. Schmidt | M. Bielaszewska | Wenlan Zhang | M. Mormann | J. Müthing | Iris Meisen | R. Bauerfeind | M. A. Schmidt | Michael Mormann
[1] G. Abu-Ali,et al. Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease. , 2011, Microbial pathogenesis.
[2] J. Matsuda,et al. High-performance thin-layer chromatography/mass spectrometry for the analysis of neutral glycosphingolipids. , 2011, Biochimica et biophysica acta.
[3] M. Mormann,et al. Thin-layer chromatography, overlay technique and mass spectrometry: a versatile triad advancing glycosphingolipidomics. , 2011, Biochimica et biophysica acta.
[4] A. Mellmann,et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. , 2011, The Lancet. Infectious diseases.
[5] J. Rothberg,et al. Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology , 2011, PloS one.
[6] T. Boppel,et al. Eculizumab in severe Shiga-toxin-associated HUS. , 2011, The New England journal of medicine.
[7] A. Friedrich,et al. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains[S] , 2011, Journal of Lipid Research.
[8] R. Kannagi,et al. Systematic analyses of free ceramide species and ceramide species comprising neutral glycosphingolipids by MALDI-TOF MS with high-energy CID , 2011, Glycoconjugate Journal.
[9] Patrik Langehanenberg,et al. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells , 2010, Thrombosis and Haemostasis.
[10] K. Sandvig,et al. Endocytosis and retrograde transport of Shiga toxin. , 2010, Toxicon : official journal of the International Society on Toxinology.
[11] T. Obrig. Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease , 2010, Toxins.
[12] F. Schaefer,et al. Treatment of typical (enteropathic) hemolytic uremic syndrome. , 2010, Seminars in thrombosis and hemostasis.
[13] A. Friedrich,et al. On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[14] A. Friedrich,et al. Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors[S] , 2010, Journal of Lipid Research.
[15] T. Beddoe,et al. Structure, biological functions and applications of the AB5 toxins. , 2010, Trends in biochemical sciences.
[16] A. Mellmann,et al. Distribution and Phylogeny of Immunoglobulin-Binding Protein G in Shiga Toxin-Producing Escherichia coli and Its Association with Adherence Phenotypes , 2010, Infection and Immunity.
[17] M. Morigi,et al. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction , 2010, Pediatric Nephrology.
[18] S. Tzipori,et al. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2. , 2010, The Journal of infectious diseases.
[19] V. Gannon,et al. Verocytotoxin-producing Escherichia coli (VTEC). , 2010, Veterinary microbiology.
[20] A. Friedrich,et al. Shiga Toxin Receptor Gb3Cer/CD77: Tumor-Association and Promising Therapeutic Target in Pancreas and Colon Cancer , 2009, PloS one.
[21] A. Friedrich,et al. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury , 2009, Thrombosis and Haemostasis.
[22] M. Murata,et al. Contribution of glycolipids to species-specific antigens on erythrocytes of several animal species as to recognition of antigens with rabbit anti-glycolipids and anti-erythrocyte antisera , 2009, Glycoconjugate Journal.
[23] L. Beutin,et al. Evaluation of Major Types of Shiga Toxin 2e-Producing Escherichia coli Bacteria Present in Food, Pigs, and the Environment as Potential Pathogens for Humans , 2008, Applied and Environmental Microbiology.
[24] A. Friedrich,et al. Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer. , 2008, Analytical chemistry.
[25] A. Friedrich,et al. New Immuno-PCR Assay for Detection of Low Concentrations of Shiga Toxin 2 and Its Variants , 2008, Journal of Clinical Microbiology.
[26] A. Friedrich,et al. Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity , 2008, Glycoconjugate Journal.
[27] L. Beutin,et al. Comparative evaluation of the Ridascreen® Verotoxin enzyme immunoassay for detection of Shiga‐toxin producing strains of Escherichia coli (STEC) from food and other sources , 2007, Journal of applied microbiology.
[28] L. Beutin,et al. Virulence profiles of Shiga toxin 2e-producing Escherichia coli isolated from healthy pig at slaughter. , 2006, Veterinary microbiology.
[29] A. Suzuki,et al. Convenient structural analysis of glycosphingolipids using MALDI-QIT-TOF mass spectrometry with increased laser power and cooling gas flow. , 2006, Journal of biochemistry.
[30] Nathan Sharon,et al. Carbohydrates as future anti-adhesion drugs for infectious diseases. , 2006, Biochimica et biophysica acta.
[31] A. Friedrich,et al. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. , 2005, Rapid communications in mass spectrometry : RCM.
[32] A. Mellmann,et al. Shiga Toxin 2e-Producing Escherichia coli Isolates from Humans and Pigs Differ in Their Virulence Profiles and Interactions with Intestinal Epithelial Cells , 2005, Applied and Environmental Microbiology.
[33] H. Karch,et al. Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.
[34] H. Karch,et al. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium , 2005, Thrombosis and Haemostasis.
[35] G. Daube,et al. Verotoxigenic Escherichia coli from animals, humans and foods: who's who? , 2005, Journal of applied microbiology.
[36] P. Tarr,et al. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.
[37] A. Friedrich,et al. Transcriptional Analysis of Genes Encoding Shiga Toxin 2 and Its Variants in Escherichia coli , 2005, Applied and Environmental Microbiology.
[38] C. Pourcel,et al. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Galα1–3Gal), blood group H determinant andN-glycolylneuraminic acid , 1996, Glycoconjugate Journal.
[39] T. Cheasty,et al. Isolation of vero cytotoxin-producingEscherichia coli serotypes O9ab:H- and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome , 1994, European Journal of Clinical Microbiology and Infectious Diseases.
[40] B. Domon,et al. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates , 1988, Glycoconjugate Journal.
[41] P. Fratamico,et al. Prevalence and Characterization of Shiga Toxin-Producing Escherichia coli in Swine Feces Recovered in the National Animal Health Monitoring System's Swine 2000 Study , 2004, Applied and Environmental Microbiology.
[42] J. Peter-Katalinic,et al. Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry. , 2004, Analytical chemistry.
[43] L. Beutin,et al. Serotyping, stx2 Subtyping, and Characterization of the Locus of Enterocyte Effacement Island of Shiga Toxin-Producing Escherichia coli and E. coli O157:H7 Strains Isolated from the Environment in France , 2004, Applied and Environmental Microbiology.
[44] L. Beutin,et al. Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated from Human Patients in Germany over a 3-Year Period , 2004, Journal of Clinical Microbiology.
[45] N. Sharon,et al. Safe as mother's milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases , 2000, Glycoconjugate Journal.
[46] M A Chester,et al. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN) Nomenclature of glycolipids: Recommendations 1997 , 1999, Glycoconjugate Journal.
[47] N. Sharon,et al. Developmental changes in neutral glycosphingolipids of mouse placenta , 1993, Glycoconjugate Journal.
[48] M. Breimer,et al. Blood group type glycosphingolipids of human kidneys. Structural characterization of extended globo-series compounds , 1991, Glycoconjugate Journal.
[49] J. Peter-Katalinic,et al. Discrimination of neolacto-series gangliosides with alpha2-3- and alpha2-6-linked N-acetylneuraminic acid by nanoelectrospray ionization low-energy collision-induced dissociation tandem quadrupole TOF MS. , 2003, Analytical chemistry.
[50] S. Elliott,et al. Forssman Synthetase Expression Results in Diminished Shiga Toxin Susceptibility , 2003, Infection and Immunity.
[51] A. Friedrich,et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.
[52] H Nakajima,et al. Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance* , 2001, The Journal of Biological Chemistry.
[53] T. Cheasty,et al. Evaluation of a reversed passive latex agglutination test for the detection of Verocytotoxin (VT) expressed by strains of VT‐producing Escherichia coli , 2001, Letters in applied microbiology.
[54] T. Voss,et al. The AIDA Autotransporter System Is Associated with F18 and Stx2e in Escherichia coli Isolates from Pigs Diagnosed with Edema Disease and Postweaning Diarrhea , 2001, Clinical Diagnostic Laboratory Immunology.
[55] S. Miyoshi,et al. Reduction of the major xenoantigen on glycosphingolipids of swine endothelial cells by various glycosyltransferases. , 2000, Glycobiology.
[56] S. Elliott,et al. Characterization of the Human Forssman Synthetase Gene , 1999, The Journal of Biological Chemistry.
[57] J. Mainil,et al. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals. , 1999, Veterinary research.
[58] M.Alan Chester,et al. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids--recommendations 1997. , 1998, European journal of biochemistry.
[59] Jcbn. Nomenclature of glycolipids , 1998 .
[60] S. Lauwers,et al. Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates , 1998, Journal of Clinical Microbiology.
[61] J. Müthing. TLC in structure and recognition studies of glycosphingolipids. , 1998, Methods in molecular biology.
[62] J. Peter-Katalinic,et al. Isolation and structural characterization of glycosphingolipids of in vitro propagated bovine aortic endothelial cells. , 1997, Glycobiology.
[63] F. Gilles,et al. Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.
[64] C. Lingwood,et al. Comparative cytotoxicity of purified Shiga-like toxin-IIe on porcine and bovine aortic endothelial and human colonic adenocarcinoma cells. , 1996, Journal of medical microbiology.
[65] J. Baenziger,et al. Expression cloning of Forssman glycolipid synthetase: a novel member of the histo-blood group ABO gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[66] C. Lingwood,et al. Interaction of verotoxin 2e with pig intestine , 1996, Infection and immunity.
[67] C. Lingwood. Role of verotoxin receptors in pathogenesis. , 1996, Trends in microbiology.
[68] J. Lehmann,et al. Isolation and structural characterization of fucosylated gangliosides with linear poly-N-acetyllactosaminyl chains from human granulocytes. , 1996, Glycobiology.
[69] A. Caprioli,et al. Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin , 1995, Journal of clinical microbiology.
[70] D. Acheson,et al. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e , 1995, Infection and immunity.
[71] J. Marks,et al. p53 in Human Cancer , 1995 .
[72] J. Peter-Katalinic,et al. Different Distributions of Glycosphingolipids in Mouse and Rabbit Skeletal Muscle Demonstrated by Biochemical and Immunohistological Analyses , 1994 .
[73] G. Tyrrell,et al. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs , 1993, The Journal of experimental medicine.
[74] H. Lior,et al. Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin , 1991, The Lancet.
[75] C. Lingwood,et al. Globotetraosylceramide is recognized by the pig edema disease toxin. , 1989, The Journal of biological chemistry.
[76] C. MacKenzie,et al. Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli. , 1988, Microbial pathogenesis.
[77] M. P. Jackson,et al. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine , 1988, Journal of bacteriology.
[78] B. Domon,et al. Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. , 1988, Biochemistry.
[79] P. Mühlradt,et al. Forssman glycolipid, an antigenic marker for a major subpopulation of macrophages from murine spleen and peripheral lymph nodes. , 1987, Journal of immunology.
[80] H. Egge,et al. Structural characterization of gangliosides from murine T lymphocytes. , 1987, European journal of biochemistry.
[81] P. Mühlradt,et al. An improved semi-quantitative enzyme immunostaining procedure for glycosphingolipid antigens on high performance thin layer chromatograms. , 1986, Journal of immunological methods.
[82] K. Karlsson,et al. Isoglobotriaosylceramide and the Forssman glycolipid of dog small intestine occupy separate tissue compartments and differ in ceramide composition. , 1983, Biochimica et biophysica acta.
[83] Joshua Jortner,et al. Nomenclature of retinoids: recommendations 1981. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). , 1983, Archives of biochemistry and biophysics.
[84] R. Yu,et al. Gangliosides: structure, isolation, and analysis. , 1982, Methods in enzymology.
[85] M. Breimer,et al. Blood group type glycosphingolipids from the small intestine of different animals analysed by mass spectrometry and thin-layer chromatography. A note on species diversity. , 1981, Journal of biochemistry.
[86] R. Yu,et al. Gangliosides of human, cat, and rabbit spinal cords and cord myelin. , 1978, Journal of lipid research.
[87] S. Roy,et al. A rapid and quantitative method for the isolation of gangliosides and neutral glycosphingolipids by DEAE-silica gel chromatography. , 1978, Journal of lipid research.
[88] J Konowalchuk,et al. Vero response to a cytotoxin of Escherichia coli , 1977, Infection and immunity.
[89] S. Hakomori,et al. Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[90] M. F. Mallette,et al. Sheep erythrocyte Forssman hapten, an isohapten system: composition of the ceramide. , 1975, Immunochemistry.
[91] M. F. Mallette,et al. Structure of Forssman hapten glycosphingolipid from sheep erythrocytes. , 1974, Immunochemistry.
[92] K. Karlsson,et al. Characterization of the forssman glycolipid hapten of horse kidney by mass spectrometry. , 1974, The Journal of biological chemistry.
[93] S. Hakomori,et al. A revised structure for the Forssman glycolipid hapten. , 1971, The Journal of biological chemistry.
[94] T. Saito,et al. Quantitative isolation of total glycosphingolipids from animal cells. , 1971, Journal of lipid research.